A new vector for controllable expression of an anti-HER2/neu mini-antibody-barnase fusion protein in HEK 293T cells

Gene

Volumn 366, Issue 1, 2006, Pages 97-103

  Glinka, Elena M ^a   Edelweiss, Eweline F ^a   Sapozhnikov, Alexander M ^a   Deyev, Sergey M ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Barstar; Fusion protein; Leader peptide; scFv 4D5; Transactivator

Indexed keywords

ANTIBODY; BARNASE; BARSTAR; ENHANCED GREEN FLUORESCENT PROTEIN; ENZYME ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYBRID PROTEIN; RIBONUCLEASE; SIGNAL PEPTIDE; TETRACYCLINE;

AFFINITY CHROMATOGRAPHY; ARTICLE; BACILLUS AMYLOLIQUEFACIENS; CELL LYSATE; CELL STRAIN HEK293; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; ENZYME INHIBITION; EUKARYOTE; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION SYSTEM; GENE VECTOR; GENETIC TRANSFECTION; HOST CELL; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PURIFICATION;

ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; CELL LINE; GENE EXPRESSION; GENE THERAPY; GENES, ERBB-2; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; NEOPLASMS; RECOMBINANT FUSION PROTEINS; RIBONUCLEASES; TETRACYCLINE; TRANSFECTION;

BACILLUS AMYLOLIQUEFACIENS; CYTOMEGALOVIRUS; EUKARYOTA;

EID: 32044474915     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2005.06.042     Document Type: Article

References (28)

1. C.M. Backman, Y. Zhang, B.J. Hoffer, and A.C. Tomac Tetracycline- inducible expression systems for the generation of transgenic animals: a comparison of various inducible systems carried in a single vector J. Neurosci. Methods 139 2004 257 262
2. R. Bhattachary, R. Bukkapatnam, I. Prawoko, J. Soto, M. Morgan, and R.R. Salup Efficacy of vaccination with plasmid DNA encoding for HER2/neu or HER2/neu-eGFP fusion protein against prostate cancer in rats Int. Immunopharmacol. 2 2002 783 796
3. Y.-M. Bi, S.J. Rothstein, and A.G. Wildeman A novel strategy for regulated expression of a cytotoxic gene Gene 279 2001 175 179
4. R.E. Bird Single-chain antigen-binding proteins Science 242 1988 423 426
5. P. Braselmann, M. Graninger, and A. Busslinger A selective transcriptional induction system for mammalian cells based on Gal4-esrogene receptor fusion proteins Proc. Natl. Acad. Sci. U. S. A. 90 1993 1657 1661
6. C. De Lorenzo A fully human antitumor immunoRNase selective for ErbB-2-positive carcinomas Cancer Res. 64 2004 4870 4874
7. S.M. Deyev, R. Waibel, E.N. Lebedenko, A.P. Shubiger, and A. Plückthun Design of multivalent complexes using the barnase*barstar module Nat. Biotechnol. 21 2003 1486 1492
8. B.R. Glick, and G.K. Whitney Factors affecting the expression of foreign proteins in Escherichia coli J. Ind. Microbiol. 1 1987 277 282
9. M. Gossen, and H. Bujard Tight control of gene expression in mammalian cells by tetracycline-responsive promoters Proc. Natl. Acad. Sci. U. S. A. 89 1992 5547 5551
10. R. Janknecht, G. de Martynoff, J. Lou, R.A. Hipskind, A. Nordheim, and H.G. Stunnenberg Rapid and efficient purification of native histidines-tagged protein expressed by recombinant vaccine virus Proc. Natl. Acad. Sci. U. S. A. 88 1991 8972 8976
11. L.-T. Jia Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase- 3 Cancer Res. 63 2003 3257 3262
12. B. Krebs High-throughput generation and engineering of recombinant human antibodies J. Immunol. Methods 254 2001 67 84
13. C.C. Lin Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu Molec. Ther. 10 2004 290 301
14. D. Lu, X. Jimenez, H. Zhang, P. Bohlen, L. Witte, and Z. Zhu Fab-scFv fusion protein: an efficient approach to production of bispecific antibody fragments J. Immunol. Methods 267 2002 213 226
15. Y. Manome, T. Kunieda, P.Y. Wen, T. Koga, D.W. Kufe, and T. Ohno Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr- 1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine Hum. Gene Ther. 9 1998 1409 1417
16. K.E. Mayo, R. Warren, and R.D. Palmiter The mouse metallothionein-I gene is transcriptionally regulated by cadmium following transfection into human or mouse cells Cell 29 1982 99 108
17. H. Mizuguchi, and T. Hayakawa Characteristics of adenovirus-mediated tetracycline-controllable expression system Biochim. Biophys. Acta 1568 2001 21 29
18. F.J. Murphy, M.P. Hayes, and P.R. Burd Disparate intracellular processing of human IL- 12 preprotein subunits: atypical processing of the P35 signal peptide J. Immunol. 164 2000 839 847
19. R.M. Neve, U.B. Nielsen, D.B. Kirpotin, M.A. Poul, J.D. Marks, and C.C. Benz Biological effects of anti-ErbB2 single chain antibodies selected for internalizing function Biochem. Biophys. Res. Commun. 280 2001 274 279
20. S. Pang Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer Hum. Gene Ther. 6 1995 1417 1426
21. I. Rubin, and Y. Yarden The basic biology of HER2 Ann. Oncol. 12 2001 3 8
22. T. Shirakawa Tissue-specific promoters in gene therapy for the treatment of prostate cancer Mol. Urol. 4 2000 73 82
23. J.S. Song Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line Biosci. Biotechnol. Biochem. 67 2003 2344 2350
24. S.C. Wang, L. Zhang, G.N. Hortobagyi, and M.C. Hung Targeting HER2: recent developments and future directions for breast cancer patients Semin. Oncol. 28 2001 21 29
25. H. Wartlick, K. Michaelis, S. Balthasar, K. Strebhardt, J. Kreuter, and K. Langer Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells J. Drug Target. 12 2004 461 471
26. G. Wilcox, and G.M. Studnicka Expression of foreign proteins in microorganisms Biotechnol. Appl. Biochem. 10 1988 500 509
27. K. Wild, K.R. Rosendal, and I. Sinning A structural step into the SRP cycle Mol. Microbiol. 53 2004 357 363
28. A.M. Wu, and P.J. Yazaki Designer genes: recombinant antibody fragments for biological imaging Q. J. Nucl. Med. 44 2000 268 283